Search results
Results from the WOW.Com Content Network
Oracle Reports is a tool for developing reports against data stored in an Oracle database. Oracle Reports consists of Oracle Reports Developer (a component of the Oracle Developer Suite ) and Oracle Application Server Reports Services (a component of the Oracle Application Server ).
This changed with Oracle RDBMS 9i release when Oracle Corporation started to standardize Oracle Forms (and Reports and Developer) to use the same major version number as the database. This explains the jump in Oracle Forms versions from 6i to 9i (there was no v7 or v8).
Oracle Developer Suite is a suite of development tools released by the Oracle Corporation. The principal components were initially Oracle Forms and Oracle Reports and the suite was later expanded to include Oracle Designer and JDeveloper amongst others.
Oracle Corporation refers to its implementation of the Java EE specification as Oracle Containers for J2EE and abbreviates the concept as OC4J. OC4J, originally based on the IronFlare Orion Application Server, has developed solely under Oracle's control since Oracle Corporation acquired the source code. OC4J includes the following servers: Web ...
A man accused of murdering two women in a suspected stabbing at a block of flats on Christmas Day has appeared in court. Joanne Pearson, 38, and Teohna Grant, 24, were pronounced dead at the scene ...
The Centers for Disease Control and Prevention (CDC) are keeping a close eye on "red flags" relating to the bird flu and whether the illness might develop into a pandemic, according to a report ...
The client-server architecture of Oracle's Developer product was typical of the 1990s; PC computers running Oracle Forms and Reports that communicated with an Oracle Database over a network protocol called SQL*NET. This structure was simpler than the software development processes that came before and was a better fit to the available technology.
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each month, an industry group told the U.S. drugs regulator in a letter ...